Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Palisade Bio (Nasdaq: PALI), a clinical-stage biopharmaceutical company specializing in autoimmune, inflammatory, and fibrotic diseases, has announced its upcoming participation in the LIVE! with Webull Corporate Connect: Healthcare Investment Webinar. JD Finley, the company's Chief Executive Officer, will present at the virtual event scheduled for Wednesday, January 29, 2025, at 2:20 PM ET.
The presentation will be part of the Virtual Biotech Investment Webinar segment of the conference, offering investors an opportunity to gain insights into Palisade Bio's developments and strategic direction in the healthcare sector.
Palisade Bio (Nasdaq: PALI), un'azienda biofarmaceutica in fase clinica specializzata in malattie autoimmuni, infiammatorie e fibrotiche, ha annunciato la sua prossima partecipazione al seminario online LIVE! con Webull Corporate Connect: Healthcare Investment Webinar. JD Finley, l'Amministratore Delegato dell'azienda, presenterà all'evento virtuale fissato per mercoledì 29 gennaio 2025, alle 14:20 ET.
La presentazione farà parte del segmento Virtual Biotech Investment Webinar della conferenza, offrendo agli investitori l'opportunità di ottenere informazioni sugli sviluppi e sulla direzione strategica di Palisade Bio nel settore sanitario.
Palisade Bio (Nasdaq: PALI), una compañía biofarmacéutica en etapa clínica especializada en enfermedades autoinmunes, inflamatorias y fibróticas, ha anunciado su próxima participación en el seminario web LIVE! con Webull Corporate Connect: Healthcare Investment Webinar. JD Finley, el Director Ejecutivo de la empresa, presentará en el evento virtual programado para miércoles 29 de enero de 2025, a las 2:20 PM ET.
La presentación será parte del segmento Virtual Biotech Investment Webinar de la conferencia, ofreciendo a los inversores la oportunidad de obtener información sobre los desarrollos y la dirección estratégica de Palisade Bio en el sector de la salud.
Palisade Bio (Nasdaq: PALI), 자가면역, 염증 및 섬유성 질환을 전문으로 하는 임상 단계의 생물 의약품 회사가 Webull Corporate Connect: Healthcare Investment Webinar의 LIVE!에 참여할 예정이라고 발표했습니다. JD Finley 회사의 최고 경영자가 2025년 1월 29일 수요일 오후 2:20 ET에 예정된 이 가상 행사에서 발표할 것입니다.
이 발표는 회의의 Virtual Biotech Investment Webinar 세션의 일환으로 진행되며, 투자자들에게 Palisade Bio의 발전과 의료 분야에서의 전략적 방향에 대한 통찰력을 제공할 기회를 제공합니다.
Palisade Bio (Nasdaq: PALI), une entreprise biopharmaceutique en phase clinique spécialisée dans les maladies auto-immunes, inflammatoires et fibrotiques, a annoncé sa prochaine participation au séminaire en ligne LIVE! avec Webull Corporate Connect : Healthcare Investment Webinar. JD Finley, le Directeur Général de l'entreprise, présentera lors de cet événement virtuel prévu pour mercredi 29 janvier 2025, à 14h20 ET.
La présentation fera partie du segment Virtual Biotech Investment Webinar de la conférence, offrant aux investisseurs l'opportunité d'obtenir des informations sur les développements et l'orientation stratégique de Palisade Bio dans le secteur de la santé.
Palisade Bio (Nasdaq: PALI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf autoimmun, entzündliche und fibrotische Erkrankungen spezialisiert hat, hat seine bevorstehende Teilnahme am LIVE! mit Webull Corporate Connect: Healthcare Investment Webinar angekündigt. JD Finley, der Geschäftsführer des Unternehmens, wird auf dem virtuellen Event präsentieren, das für Mittwoch, den 29. Januar 2025, um 14:20 Uhr ET geplant ist.
Die Präsentation wird Teil des Segments Virtual Biotech Investment Webinar der Konferenz sein und den Investoren die Möglichkeit bieten, Einblicke in die Entwicklungen und strategische Ausrichtung von Palisade Bio im Gesundheitssektor zu gewinnen.
- None.
- None.
Live webcast on Wednesday, January 29th at 2:20 PM ET
Carlsbad, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that JD Finley, Chief Executive Officer of Palisade will present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar being held on January 29, 2025.
Conference Details:
Conference: LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Date/Time: Wednesday, January 29, 2025 at 2:20 PM ET
Presenter: JD Finley, Chief Executive Officer
Registration Link: HERE
About Webull Financial
Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC (“Webull Financial”), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit www.webull.com.
About Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com
FAQ
When is Palisade Bio (PALI) presenting at the Webull Healthcare Investment Webinar?
What therapeutic areas does Palisade Bio (PALI) focus on?
Who will be representing Palisade Bio (PALI) at the Webull Healthcare Investment Webinar?
Is the Palisade Bio (PALI) Webull presentation virtual or in-person?
